Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Shares Outstanding (Diluted Average) (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Shares Outstanding (Diluted Average) for 17 consecutive years, with $18.6 million as the latest value for Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) fell 3.07% to $18.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $18.6 million through Jan 2026, down 3.07% year-over-year, with the annual reading at $18.6 million for FY2026, 3.07% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 was $18.6 million at Usana Health Sciences, up from $18.3 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $20.3 million in Q1 2022, with the low at $18.3 million in Q3 2025.
  • Average Shares Outstanding (Diluted Average) over 5 years is $19.2 million, with a median of $19.3 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Diluted Average) fell 7.66% in 2022, then increased 0.69% in 2023.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $19.3 million in 2022, then grew by 0.18% to $19.3 million in 2023, then decreased by 0.95% to $19.2 million in 2024, then dropped by 4.54% to $18.3 million in 2025, then rose by 1.54% to $18.6 million in 2026.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $18.6 million, $18.3 million, and $18.8 million for Q1 2026, Q3 2025, and Q2 2025 respectively.